
Sign up to save your podcasts
Or
2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients.
Follow us on LinkedIn, X, Facebook and Instagram.
Visit us at https://www.bio.org/
4.9
8383 ratings
2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients.
Follow us on LinkedIn, X, Facebook and Instagram.
Visit us at https://www.bio.org/
6,133 Listeners
941 Listeners
461 Listeners
756 Listeners
811 Listeners
2,052 Listeners
309 Listeners
122 Listeners
318 Listeners
59 Listeners
147 Listeners